Interestingly, our PAH iPSCs successfully differentiated towards iPSC-CMs despite carrying a heterozygous mutation in the BMPR2 gene, to which bone morphogenetic protein 4 (BMP4) preferentially binds [21]. Here, BMPR2 is linked to pulmonary arterial hypertension.